Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Bellevue
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Bellevue, WA

Studies commonly pay $75 to $4,500 per completed study

1,518 clinical trials are currently recruiting participants within 30 miles of Bellevue. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,518studies recruiting
6+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Bellevue right now

Top 25 of 1,518 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Valley Medical Center /ID# 253950 — Renton, Washington (8.3 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Seattle Children's Hospital — Seattle, Washington (8.4 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
Washington Center for Bleeding Disorders — Seattle, Washington (8.4 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Seattle Children's Hospital — Seattle, Washington (8.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult, Metastatic Breast Cancer Phase 1 Interventional 392 participants sought
Fred Hutchinson Cancer Center — Seattle, Washington (8.4 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See eligibility & contact on ClinicalTrials.gov (NCT06625775)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
Swedish Cancer Institute - Issaquah — Seattle, Washington (8.4 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Rainier Clinical Research Center — Renton, Washington (8.3 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Advanced Renal Cell Carcinoma (RCC) Phase 1, Phase 2 Interventional 474 participants sought
Local Institution - 0095 — Seattle, Washington (8.4 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07293351)

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Dravet Syndrome Phase 1, Phase 2 Interventional 32 participants sought
Seattle Children's Hospital — Seattle, Washington (8.4 mi) · Sponsor: Ionis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07531745)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Swedish Cancer Institute — Seattle, Washington (8.4 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Follicular Lymphoma, Marginal Zone Lymphoma Phase 1, Phase 2 Interventional 80 participants sought
University of Washington-Seattle Cancer Care Alliance — Seattle, Washington (8.4 mi) · Sponsor: Enterome
See eligibility & contact on ClinicalTrials.gov (NCT04669171)

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 Phase 1, Phase 2 Interventional 10 participants sought
University of Washington Medical Center — Seattle, Washington (8.4 mi) · Sponsor: AskBio Inc
See eligibility & contact on ClinicalTrials.gov (NCT05230459)

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

Prematurity, Iron-deficiency Phase 2 Interventional 120 participants sought
University of Washington — Seattle, Washington (8.4 mi) · Sponsor: University of Washington
See eligibility & contact on ClinicalTrials.gov (NCT05340465)

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Crohn Disease N/A Interventional 60 participants sought
Seattle Children's Hospital — Seattle, Washington (8.4 mi) · Sponsor: Seattle Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06216899)

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Mild Cognitive Impairment (MCI), Cognitive Training Phase 2 Interventional 240 participants sought
University of Washington — Seattle, Washington (8.4 mi) · Sponsor: Columbia University
See eligibility & contact on ClinicalTrials.gov (NCT06601933)

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Retinoblastoma Bilateral, Retinoblastoma Unilateral N/A Observational 100 participants sought
University of Washington — Seattle, Washington (8.4 mi) · Sponsor: University of Washington
See eligibility & contact on ClinicalTrials.gov (NCT06725173)

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Prostate Cancer Phase 3 Interventional 940 participants sought
Swedish Medical Center — Seattle, Washington (8.4 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06855277)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Seattle, Washington (8.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Obesity, Overweight Phase 3 Interventional 300 participants sought
Rainier Clin Res Ctr Inc — Renton, Washington (8.3 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07571109)

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Atherosclerosis, Cardiovascular Diseases Phase 3 Interventional 252 participants sought
Eastside Research Associates — Redmond, Washington (5.7 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07613294)
Actively enrolling

Studies you may be able to join near Bellevue

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Bellevue

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

DM Clinical Research — Seattle

★ 4.9
600 Broadway, Seattle, WA 98122
(425) 399-8006
"Very professional. Very nice they furnish u er ride when needed"
— Gretchen Schmidt, 4★

Clinical Research Center at Minor

★ 4.7
820 Minor Ave N, Seattle, WA 98109
(206) 667-7100
"Wonderful staff, supportive environment"
— Susan Mausshardt, 5★

Clinical Research Center

Seattle, WA 98195

Clinical trials in Bellevue: what's recruiting

The Bellevue area currently has 1,518 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Bellevue, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney1 studies
  • Immune & Skin1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Bellevue, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Bellevue

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Bellevue participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Bellevue?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Bellevue safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Bellevue?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Bellevue.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Bellevue typically complete one or two studies per year.

Paid clinical trials near Bellevue

Other metros within reach

Seattle, WA1,511 Tacoma, WA1,461 Marysville, WA204 Bremerton, WA1,482 Olympia, WA228 Vancouver, WA1,030 Portland, OR1,030 Salem, OR112

By condition

Eligibility and exclusions, condition by condition

MASH (cirrhosis due to MASH) in Bellevue Bladder Issues Due To Spinal Cord Injury in Bellevue All conditions

More of WA

Seattle1,511 Bremerton1,482 Tacoma1,461 Vancouver1,030 Spokane296 Olympia228 Marysville204 Kennewick55

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts